Work in progress! Dr. Shahin Jamal and Dr. Tom Appleton are leading a study on Early Adalimumab Induction for Treatment of Steroid-Dependent Checkpoint Inhibitor Associated Inflammatory Arthritis: A Pragmatic Randomized Clinical Trial. They are recipients of a 2023 Canadian Initiative for Outcomes in Rheumatology cAre (CIORA) grant from the Canadian Rheumatology Association Foundation (CRAF) to support this study.